Report cover image

Global 1-Fluorocyclopropane-1-Sulfonamide Market Growth 2023-2029

Published Jun 29, 2023
Length 96 Pages
SKU # LPI18026425

Description

Global 1-Fluorocyclopropane-1-Sulfonamide Market Growth 2023-2029


The global 1-Fluorocyclopropane-1-Sulfonamide market size is projected to grow from US$ 677.9 million in 2022 to US$ 972.5 million in 2029; it is expected to grow at a CAGR of 5.3% from 2023 to 2029.

United States market for 1-Fluorocyclopropane-1-Sulfonamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for 1-Fluorocyclopropane-1-Sulfonamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for 1-Fluorocyclopropane-1-Sulfonamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key 1-Fluorocyclopropane-1-Sulfonamide players cover Gravita India Ltd, BASF SE, LEAP CHEM CO., LTD., Shanghai Yuhan Chemical Co., Ltd., Guangzhou Kangruitai Pharmaceutical Co., Ltd., Chengdu Zeibai Pharmaceutical Technology Co., Ltd. and Hubei Yangxin Pharmaceutical Technology Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

1-Fluorocyclopropane-1-sulfonamide (FCS) is an organic compound that is used in a variety of scientific applications, including synthesis, research, and lab experiments. FCS is a fluorinated cyclopropane sulfonamide, consisting of a cyclopropane ring with a sulfonamide group and a fluorinated substituent attached to the nitrogen atom. This compound has several unique properties that make it suitable for use in a wide range of applications.

LPI (LP Information)' newest research report, the “1-Fluorocyclopropane-1-Sulfonamide Industry Forecast” looks at past sales and reviews total world 1-Fluorocyclopropane-1-Sulfonamide sales in 2022, providing a comprehensive analysis by region and market sector of projected 1-Fluorocyclopropane-1-Sulfonamide sales for 2023 through 2029. With 1-Fluorocyclopropane-1-Sulfonamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 1-Fluorocyclopropane-1-Sulfonamide industry.

This Insight Report provides a comprehensive analysis of the global 1-Fluorocyclopropane-1-Sulfonamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 1-Fluorocyclopropane-1-Sulfonamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global 1-Fluorocyclopropane-1-Sulfonamide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 1-Fluorocyclopropane-1-Sulfonamide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 1-Fluorocyclopropane-1-Sulfonamide.

This report presents a comprehensive overview, market shares, and growth opportunities of 1-Fluorocyclopropane-1-Sulfonamide market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
≤95%
>95%

Segmentation by application
Chemical Industry
Experimental Reagent
Drug Intermediate

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Gravita India Ltd
BASF SE
LEAP CHEM CO., LTD.
Shanghai Yuhan Chemical Co., Ltd.
Guangzhou Kangruitai Pharmaceutical Co., Ltd.
Chengdu Zeibai Pharmaceutical Technology Co., Ltd.
Hubei Yangxin Pharmaceutical Technology Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global 1-Fluorocyclopropane-1-Sulfonamide market?

What factors are driving 1-Fluorocyclopropane-1-Sulfonamide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 1-Fluorocyclopropane-1-Sulfonamide market opportunities vary by end market size?

How does 1-Fluorocyclopropane-1-Sulfonamide break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

96 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global 1-Fluorocyclopropane-1-Sulfonamide by Company
4 World Historic Review for 1-Fluorocyclopropane-1-Sulfonamide by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for 1-Fluorocyclopropane-1-Sulfonamide by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.